CLAUDIA CHAR: Open Payments
NPI 1194449256 · CORAL GABLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,922 in 111 payments from 20 companies in 2025. Trend: 2023 $1,425 · 2024 $1,090 · 2025 $3,922
Food & beverage: $3,922
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 17 | $582 |
| UCB, Inc. | 11 | $496 |
| ABBVIE INC. | 23 | $401 |
| Galderma Laboratories, L.P. | 7 | $284 |
| Janssen Biotech, Inc. | 3 | $278 |
| PFIZER INC. | 11 | $262 |
| REVANCE THERAPEUTICS, INC. | 4 | $253 |
| Journey Medical Corporation | 2 | $235 |
| Arcutis Biotherapeutics, Inc. | 6 | $216 |
| Regeneron Healthcare Solutions, Inc. | 6 | $216 |
Products named: OPZELURA, Bimzelx, DUPIXENT, RINVOQ, TREMFYA, NEMLUVIO, DAXXIFY, Zoryve.
Industry payments across FL — which companies pay providers there.
